Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;61(7):4381-4390.
doi: 10.1007/s12035-023-03841-7. Epub 2023 Dec 12.

The Protective Mechanism of TFAM on Mitochondrial DNA and its Role in Neurodegenerative Diseases

Ying Song  1   2 , Wenjun Wang  3 , Beibei Wang  3 , Qiwen Shi  3
Affiliations
Review

The Protective Mechanism of TFAM on Mitochondrial DNA and its Role in Neurodegenerative Diseases

Ying Song et al. Mol Neurobiol. 2024 Jul.

Abstract

Mitochondrial transcription factor A (TFAM) is a mitochondrial protein encoded by nuclear genes and transported from the cytoplasm to the mitochondria. TFAM is essential for the maintenance, expression, and delivery of mitochondrial DNA (mtDNA) and can regulate the replication and transcription of mtDNA. TFAM is associated with the formation of mtDNA nucleomimetic structures, mtDNA repair, and mtDNA stability. However, the mechanism by which TFAM protects mtDNA is still being studied. This review provides a summary of the protective mechanism of TFAM on mtDNA including the discrete regulatory effects of TFAM acetylation and phosphorylation on mtDNA, the regulation of Ca2+ levels by TFAM to activate transcription in mitochondria, and the increased binding of TFAM to mtDNA damage hot spots. This review also discusses the association between TFAM and some neurodegenerative diseases.

Keywords: Mitochondria; Mitochondrial DNA; Mitochondrial transcription factor A; Neurodegenerative diseases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Annesley SJ, Fisher PR (2019) Mitochondria in health and disease. Cells 8(7). https://doi.org/10.3390/cells8070680
    1. Cannino G, Ferruggia E, Luparello C, Rinaldi AM (2009) Cadmium and mitochondria. Mitochondrion 9(6):377–384. https://doi.org/10.1016/j.mito.2009.08.009 - DOI - PubMed
    1. Bonora M, Missiroli S, Perrone M, Fiorica F, Pinton P, Giorgi C (2021) Mitochondrial control of genomic instability in cancer. Cancers 13(8). https://doi.org/10.3390/cancers13081914
    1. El-Hattab AW, Scaglia F (2016) Mitochondrial cytopathies. Cell Calcium 60(3):199–206. https://doi.org/10.1016/j.ceca.2016.03.003 - DOI - PubMed
    1. Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J, Hoyle R, Holtzman DM (2019) Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med 216(11):2546–2561. https://doi.org/10.1084/jem.20190980 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources